While PrRP31 analogues with dual GPR10-NPFF2R agonism might show potential as novel anti-obesity agents, preclinical evidence indicate that NPFF2R also plays a role in central cardiovascular control55. This evidence concerns the gene PRLHR and obesity disorder.